Lantz Financial LLC Sells 1,727 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Lantz Financial LLC cut its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 9.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,727 shares of the pharmacy operator’s stock after selling 1,727 shares during the quarter. Lantz Financial LLC’s holdings in Walgreens Boots Alliance were worth $147,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brooklyn Investment Group lifted its holdings in Walgreens Boots Alliance by 21.1% in the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after buying an additional 830 shares during the period. First Financial Corp IN lifted its stake in shares of Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock valued at $25,000 after purchasing an additional 885 shares during the period. Sequoia Financial Advisors LLC lifted its stake in shares of Walgreens Boots Alliance by 4.4% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after purchasing an additional 1,063 shares during the period. Lincluden Management Ltd. lifted its stake in shares of Walgreens Boots Alliance by 0.4% in the 3rd quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock valued at $2,371,000 after purchasing an additional 1,074 shares during the period. Finally, CWA Asset Management Group LLC lifted its stake in shares of Walgreens Boots Alliance by 9.2% in the 4th quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock valued at $120,000 after purchasing an additional 1,084 shares during the period. 58.59% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on WBA. Barclays raised their target price on Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research note on Wednesday, October 16th. Truist Financial raised their target price on Walgreens Boots Alliance from $10.00 to $13.00 and gave the company a “hold” rating in a research note on Thursday, January 16th. Jefferies Financial Group lowered their target price on Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, October 23rd. Bank of America raised their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research note on Monday, January 13th. Finally, Royal Bank of Canada lifted their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a research note on Wednesday, January 15th. Four equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Walgreens Boots Alliance currently has an average rating of “Hold” and an average price target of $13.27.

Walgreens Boots Alliance Trading Up 1.1 %

Walgreens Boots Alliance stock opened at $11.87 on Friday. The stock has a fifty day simple moving average of $9.86 and a two-hundred day simple moving average of $9.88. Walgreens Boots Alliance, Inc. has a 12 month low of $8.08 and a 12 month high of $23.76. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. The business had revenue of $39.50 billion during the quarter, compared to analyst estimates of $37.40 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.66 EPS. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 1.59 EPS for the current year.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.